Model-based estimates of deaths averted and cost per life saved by scaling-up mRNA COVID-19 vaccination in low and lower-middle income countries in the COVID-19 Omicron variant era
View ORCID ProfileAlexandra Savinkina, Alyssa Bilinski, View ORCID ProfileMeagan C. Fitzpatrick, View ORCID ProfileA. David Paltiel, Zain Rizvi, View ORCID ProfileJoshua A. Salomon, Tommy Thornhill, Gregg Gonsalves
doi: https://doi.org/10.1101/2022.02.08.22270465
Alexandra Savinkina
1Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT
2Public Health Modeling Unit, Yale School of Public Health, New Haven, CT
MSPHAlyssa Bilinski
3Departments of Health Services, Policy, and Practice & Biostatistics, Brown University School of Public Health, Providence, RI
PhDMeagan C. Fitzpatrick
4Center for Vaccine Development and Global Health, University of Maryland School of Medicine
PhDA. David Paltiel
2Public Health Modeling Unit, Yale School of Public Health, New Haven, CT
5Department of Health Policy and Management, Yale School of Public Health, New Haven, CT
PhDZain Rizvi
6Public Citizen, Washington, DC
JDJoshua A. Salomon
7Department of Health Policy, Stanford University, Palo Alto, CA USA
PhDTommy Thornhill
1Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT
2Public Health Modeling Unit, Yale School of Public Health, New Haven, CT
MPHGregg Gonsalves
1Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT
2Public Health Modeling Unit, Yale School of Public Health, New Haven, CT
PhD
Data Availability
This study used only publicly available data sources.
Posted February 09, 2022.
Model-based estimates of deaths averted and cost per life saved by scaling-up mRNA COVID-19 vaccination in low and lower-middle income countries in the COVID-19 Omicron variant era
Alexandra Savinkina, Alyssa Bilinski, Meagan C. Fitzpatrick, A. David Paltiel, Zain Rizvi, Joshua A. Salomon, Tommy Thornhill, Gregg Gonsalves
medRxiv 2022.02.08.22270465; doi: https://doi.org/10.1101/2022.02.08.22270465
Model-based estimates of deaths averted and cost per life saved by scaling-up mRNA COVID-19 vaccination in low and lower-middle income countries in the COVID-19 Omicron variant era
Alexandra Savinkina, Alyssa Bilinski, Meagan C. Fitzpatrick, A. David Paltiel, Zain Rizvi, Joshua A. Salomon, Tommy Thornhill, Gregg Gonsalves
medRxiv 2022.02.08.22270465; doi: https://doi.org/10.1101/2022.02.08.22270465
Subject Area
Subject Areas
- Addiction Medicine (280)
- Allergy and Immunology (580)
- Anesthesia (141)
- Cardiovascular Medicine (1968)
- Dermatology (188)
- Emergency Medicine (336)
- Epidemiology (11128)
- Gastroenterology (631)
- Genetic and Genomic Medicine (3204)
- Geriatric Medicine (310)
- Health Economics (568)
- Health Informatics (2054)
- Health Policy (864)
- Hematology (311)
- HIV/AIDS (686)
- Medical Education (319)
- Medical Ethics (92)
- Nephrology (339)
- Neurology (3005)
- Nursing (167)
- Nutrition (466)
- Oncology (1566)
- Ophthalmology (478)
- Orthopedics (189)
- Otolaryngology (267)
- Pain Medicine (204)
- Palliative Medicine (57)
- Pathology (404)
- Pediatrics (916)
- Primary Care Research (357)
- Public and Global Health (5620)
- Radiology and Imaging (1104)
- Respiratory Medicine (765)
- Rheumatology (342)
- Sports Medicine (291)
- Surgery (351)
- Toxicology (48)
- Transplantation (159)
- Urology (133)